ILLUMINA INC
For the period ended Dec 31, 2023. Filed Feb 16, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 16, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
7. Supplemental Balance Sheet and Statement of Operations Details
Accounts Receivable
| In millions | December 31,2023 | January 1,2023 |
|---|---|---|
| Trade accounts receivable, gross | $741 | $675 |
| Allowance for credit losses | (7) | (4) |
| Total accounts receivable, net | $734 | $671 |
Inventory
| In millions | December 31,2023 | January 1,2023 |
|---|---|---|
| Raw materials | $276 | $247 |
| Work in process | 402 | 386 |
| Finished goods | 30 | 28 |
| Inventory, gross | 708 | 661 |
| Inventory reserve | (121) | (93) |
| Total inventory, net | $587 | $568 |
Property and Equipment
| In millions | December 31,2023 | January 1,2023 |
|---|---|---|
| Leasehold improvements | $803 | $759 |
| Machinery and equipment | 684 | 644 |
| Computer hardware and software | 463 | 424 |
| Furniture and fixtures | 55 | 50 |
| Buildings | 44 | 44 |
| Construction in progress | 96 | 132 |
| Total property and equipment, gross | 2,145 | 2,053 |
| Accumulated depreciation | (1,138) | (962) |
| Total property and equipment, net | $1,007 | $1,091 |
Property and equipment, net included non-cash expenditures of $12 million, $16 million and $17 million in 2023, 2022, and 2021, respectively, which were excluded from the consolidated statements of cash flows.
Accrued Liabilities
| In millions | December 31,2023 | January 1,2023 |
|---|---|---|
| Legal contingencies(1) | $484 | $473 |
| Contract liabilities, current portion | 252 | 245 |
| Accrued compensation expenses(2) | 223 | 188 |
| Accrued taxes payable | 79 | 97 |
| Operating lease liabilities, current portion | 86 | 76 |
| Liability-classified equity incentive awards | 55 | 36 |
| Other, including warranties(3) | 146 | 117 |
| Total accrued liabilities | $1,325 | $1,232 |
(1)See note “8. Legal Proceedings” for additional details.
(2)Included employee separation costs related to restructuring activities.
(3)See table below for changes in the reserve for product warranties.
Changes in the reserve for product warranties were as follows:
| In millions | |
|---|---|
| Balance as of January 3, 2021 | $13 |
| Additions charged to cost of product revenue | 33 |
| Repairs and replacements | (24) |
| Balance as of January 2, 2022 | 22 |
| Additions charged to cost of product revenue | 23 |
| Repairs and replacements | (27) |
| Balance as of January 1, 2023 | 18 |
| Additions charged to cost of product revenue | 42 |
| Repairs and replacements | (39) |
| Balance as of December 31, 2023 | $21 |
Restructuring
In Q2 2023, we implemented a cost reduction initiative that included workforce reductions, the consolidation of certain facilities and other actions to reduce expenses, all as part of a plan to realign operating expenses while maintaining focus on our innovation roadmap and sustainable long-term growth. In 2023, we recorded pre-tax restructuring charges primarily consisting of asset impairment charges related to our facilities and employee separation costs.
A summary of the pre-tax restructuring charges recorded in 2023 are as follows:
| In millions | |
|---|---|
| Employee separation costs | $48 |
| Asset impairment charges (1) | 100 |
| Other costs | 4 |
| Total restructuring charges (2) | $152 |
(1)Primarily related to impairment of right-of-use assets and leasehold improvements for our i3 and Foster City campuses in California.
(2)For 2023, $122 million was recorded in SG&A expense, $24 million in R&D expense, with the remainder recorded in cost of revenue. These restructuring activities primarily relate to our Core Illumina segment.
During 2023, we fully exited our i3 campus in San Diego, California, which resulted in a right-of-use asset impairment of $38 million, and we exited a portion of our campus in Foster City, California, which resulted in a right-of-use asset impairment of $21 million. These impairments were recognized in selling, general and administrative expense. The impairments were determined by comparing the fair value of the impacted right-of-use asset to the carrying value of the asset as of the impairment measurement date. The fair value of the right-of-use asset was estimated using the discounted future cash flows method, which includes estimates and assumptions for future sublease rental rates that reflect current sublease market conditions, as well as a discount rate. The estimates and assumptions used in our assessment represent a Level 3 measurement because they are supported by little or no market activity and reflect our own assumptions in measuring fair value. We also recorded $16 million and $22 million of leasehold improvement impairments related to the exits of our i3 and Foster City campuses, respectively, in 2023, recognized in selling, general and administrative expense. We continue to evaluate our options with respect to the rest of our campus in Foster City, California. As of December 31, 2023, we had remaining assets, consisting primarily of right-of-use assets and leasehold improvements, related to our Foster City campus of approximately $136 million.
A summary of the restructuring liability is as follows:
| In millions | Employee Separation Costs (1) | Other Costs | Total |
|---|---|---|---|
| Expense recorded in 2023 | $48 | $4 | $52 |
| Cash paid during 2023 | (31) | (3) | (34) |
| Amount recorded in accrued liabilities as of YTD 2023 | $17 | $1 | $18 |
| Estimated total restructuring costs to still be incurred | $8 | $— | $8 |
(1)It is expected that substantially all of the employee separation related restructuring charges will be incurred and paid by the end of Q1 2024.
Other (Expense) Income, Net
| In millions | 2023 | 2022 | 2021 |
|---|---|---|---|
| Gain on previously held investment in GRAIL | $— | $— | $899 |
| Gain on exchange of GRAIL contingent value rights | — | — | 86 |
| Gain (loss) on Helix contingent value right | 10 | (7) | 30 |
| Gain on derivative assets related to terminated acquisition | — | — | 26 |
| (Losses) gains on strategic investments, net | (40) | (122) | 18 |
| Other | 1 | (13) | 9 |
| Other (expense) income, net | $(29) | $(142) | $1,068 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.